| Product Code: ETC13301314 | Publication Date: Apr 2025 | Updated Date: Jul 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Ravi Bhandari | No. of Pages: 190 | No. of Figures: 80 | No. of Tables: 40 |
According to 6Wresearch internal database and industry insights, the Global Chronic Urticaria Market was valued at USD 2.9 Billion in 2024 and is expected to reach USD 4.5 Billion by 2031, growing at a compound annual growth rate of 6.06% during the forecast period (2025-2031).
The Global Chronic Urticaria Market is witnessing steady growth due to the increasing prevalence of chronic urticaria worldwide. Chronic urticaria, also known as chronic hives, is a skin condition characterized by recurring hives or wheals that last for more than six weeks. The market is driven by the rising awareness about the condition among patients and healthcare providers, leading to early diagnosis and treatment. The market is also fueled by advancements in diagnostic techniques and treatment options, including antihistamines, corticosteroids, and biologic therapies. Key players in the market are focusing on research and development activities to introduce innovative therapies and improve patient outcomes. However, challenges such as high treatment costs and potential side effects may hinder market growth to some extent. Overall, the Global Chronic Urticaria Market is expected to continue expanding as the prevalence of chronic urticaria rises and treatment options evolve.
The Global Chronic Urticaria Market is witnessing a growing demand for advanced treatment options due to the increasing prevalence of chronic urticaria worldwide. The market is driven by the rising awareness about the condition among healthcare professionals and patients, leading to early diagnosis and treatment. There is a significant opportunity for pharmaceutical companies to develop innovative therapies that target the underlying causes of chronic urticaria, such as autoimmune disorders or allergies. Additionally, the market is seeing a trend towards personalized medicine, with a focus on precision therapies tailored to individual patient needs. The increasing investment in research and development activities for chronic urticaria treatments is expected to drive market growth in the coming years.
The Global Chronic Urticaria Market faces several challenges, including limited awareness about the condition among both patients and healthcare providers, leading to underdiagnosis and undertreatment. Additionally, the heterogeneous nature of chronic urticaria makes it difficult to identify effective treatments for all patients, resulting in trial-and-error approaches that can be time-consuming and frustrating for both patients and healthcare professionals. Furthermore, the high cost of some treatments and lack of insurance coverage in certain regions can pose financial barriers to accessing care. Lastly, the unpredictable and chronic nature of urticaria can significantly impact patients` quality of life, highlighting the need for more holistic management strategies that address not only the physical symptoms but also the emotional and social aspects of living with this condition.
The Global Chronic Urticaria Market is primarily driven by increasing prevalence of chronic urticaria worldwide, growing awareness among patients and healthcare professionals about the condition, advancements in diagnostic technologies, and the availability of a wide range of treatment options including antihistamines, corticosteroids, and biologics. Additionally, the rising healthcare expenditure, improving access to healthcare facilities, and the expanding geriatric population are contributing to the market growth. Furthermore, ongoing research and development activities aimed at developing novel therapies and personalized treatment options for chronic urticaria are expected to fuel the market expansion in the coming years. The increasing focus on patient-centric care and the adoption of innovative treatment approaches are also key factors driving the growth of the Global Chronic Urticaria Market.
Government policies related to the Global Chronic Urticaria Market typically focus on regulation of pharmaceutical products, healthcare services, and research funding. Regulatory bodies such as the FDA in the United States and the EMA in Europe play a crucial role in approving and monitoring the safety and efficacy of chronic urticaria treatments. Government healthcare policies may also impact access to these treatments for patients, with reimbursement policies and insurance coverage influencing market dynamics. Additionally, governments may allocate funding for research initiatives in the field of chronic urticaria, aiming to support the development of innovative therapies and improve patient outcomes. Overall, government policies in this market aim to ensure the availability of safe and effective treatments, promote research advancements, and enhance patient access to care.
The Global Chronic Urticaria Market is expected to witness steady growth in the coming years, driven by factors such as increasing prevalence of chronic urticaria, advancements in diagnostic techniques, and rising awareness about the condition among healthcare professionals and patients. The market is also likely to benefit from the introduction of novel treatment options and therapies, along with ongoing research and development activities focused on improving patient outcomes. Additionally, the growing healthcare expenditure worldwide and expanding access to healthcare services in emerging economies are anticipated to further fuel market growth. However, challenges such as high treatment costs and limited availability of effective therapies may hinder market expansion to some extent. Overall, the Global Chronic Urticaria Market is poised for continued growth and innovation in the foreseeable future.
In the Global Chronic Urticaria Market, Asia is expected to witness significant growth due to the rising prevalence of the condition in countries like China and India. North America is likely to dominate the market with a large patient pool and advanced healthcare infrastructure. Europe is anticipated to show steady growth owing to increasing awareness about chronic urticaria and availability of treatment options. In the Middle East and Africa region, the market is projected to expand gradually as healthcare systems continue to improve. Latin America is also expected to demonstrate growth with improving access to healthcare services and a growing focus on chronic disease management. Overall, the global chronic urticaria market is set to grow across all regions, driven by factors such as increasing disease prevalence, rising healthcare expenditure, and advancements in treatment options.
Global Chronic Urticaria Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Global Chronic Urticaria Market Overview |
3.1 Global Regional Macro Economic Indicators |
3.2 Global Chronic Urticaria Market Revenues & Volume, 2021 & 2031F |
3.3 Global Chronic Urticaria Market - Industry Life Cycle |
3.4 Global Chronic Urticaria Market - Porter's Five Forces |
3.5 Global Chronic Urticaria Market Revenues & Volume Share, By Regions, 2021 & 2031F |
3.6 Global Chronic Urticaria Market Revenues & Volume Share, By Therapeutic Class, 2021 & 2031F |
3.7 Global Chronic Urticaria Market Revenues & Volume Share, By Route of Administration, 2021 & 2031F |
3.8 Global Chronic Urticaria Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
4 Global Chronic Urticaria Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 Global Chronic Urticaria Market Trends |
6 Global Chronic Urticaria Market, 2021 - 2031 |
6.1 Global Chronic Urticaria Market, Revenues & Volume, By Therapeutic Class, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 Global Chronic Urticaria Market, Revenues & Volume, By Antihistamines, 2021 - 2031 |
6.1.3 Global Chronic Urticaria Market, Revenues & Volume, By H2 Blockers, 2021 - 2031 |
6.1.4 Global Chronic Urticaria Market, Revenues & Volume, By Antidepressants, 2021 - 2031 |
6.1.5 Global Chronic Urticaria Market, Revenues & Volume, By Monoclonal Antibodies, 2021 - 2031 |
6.1.6 Global Chronic Urticaria Market, Revenues & Volume, By Others, 2021 - 2031 |
6.2 Global Chronic Urticaria Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 Global Chronic Urticaria Market, Revenues & Volume, By Oral, 2021 - 2031 |
6.2.3 Global Chronic Urticaria Market, Revenues & Volume, By Parenteral, 2021 - 2031 |
6.2.4 Global Chronic Urticaria Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 Global Chronic Urticaria Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 Global Chronic Urticaria Market, Revenues & Volume, By Hospital Pharmacy, 2021 - 2031 |
6.3.3 Global Chronic Urticaria Market, Revenues & Volume, By Online Pharmacy, 2021 - 2031 |
6.3.4 Global Chronic Urticaria Market, Revenues & Volume, By Retail Pharmacy, 2021 - 2031 |
6.3.5 Global Chronic Urticaria Market, Revenues & Volume, By Others, 2021 - 2031 |
7 North America Chronic Urticaria Market, Overview & Analysis |
7.1 North America Chronic Urticaria Market Revenues & Volume, 2021 - 2031 |
7.2 North America Chronic Urticaria Market, Revenues & Volume, By Countries, 2021 - 2031 |
7.2.1 United States (US) Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
7.2.2 Canada Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
7.2.3 Rest of North America Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
7.3 North America Chronic Urticaria Market, Revenues & Volume, By Therapeutic Class, 2021 - 2031 |
7.4 North America Chronic Urticaria Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
7.5 North America Chronic Urticaria Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
8 Latin America (LATAM) Chronic Urticaria Market, Overview & Analysis |
8.1 Latin America (LATAM) Chronic Urticaria Market Revenues & Volume, 2021 - 2031 |
8.2 Latin America (LATAM) Chronic Urticaria Market, Revenues & Volume, By Countries, 2021 - 2031 |
8.2.1 Brazil Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
8.2.2 Mexico Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
8.2.3 Argentina Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
8.2.4 Rest of LATAM Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
8.3 Latin America (LATAM) Chronic Urticaria Market, Revenues & Volume, By Therapeutic Class, 2021 - 2031 |
8.4 Latin America (LATAM) Chronic Urticaria Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
8.5 Latin America (LATAM) Chronic Urticaria Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
9 Asia Chronic Urticaria Market, Overview & Analysis |
9.1 Asia Chronic Urticaria Market Revenues & Volume, 2021 - 2031 |
9.2 Asia Chronic Urticaria Market, Revenues & Volume, By Countries, 2021 - 2031 |
9.2.1 India Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
9.2.2 China Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
9.2.3 Japan Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
9.2.4 Rest of Asia Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
9.3 Asia Chronic Urticaria Market, Revenues & Volume, By Therapeutic Class, 2021 - 2031 |
9.4 Asia Chronic Urticaria Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
9.5 Asia Chronic Urticaria Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
10 Africa Chronic Urticaria Market, Overview & Analysis |
10.1 Africa Chronic Urticaria Market Revenues & Volume, 2021 - 2031 |
10.2 Africa Chronic Urticaria Market, Revenues & Volume, By Countries, 2021 - 2031 |
10.2.1 South Africa Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
10.2.2 Egypt Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
10.2.3 Nigeria Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
10.2.4 Rest of Africa Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
10.3 Africa Chronic Urticaria Market, Revenues & Volume, By Therapeutic Class, 2021 - 2031 |
10.4 Africa Chronic Urticaria Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
10.5 Africa Chronic Urticaria Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
11 Europe Chronic Urticaria Market, Overview & Analysis |
11.1 Europe Chronic Urticaria Market Revenues & Volume, 2021 - 2031 |
11.2 Europe Chronic Urticaria Market, Revenues & Volume, By Countries, 2021 - 2031 |
11.2.1 United Kingdom Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
11.2.2 Germany Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
11.2.3 France Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
11.2.4 Rest of Europe Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
11.3 Europe Chronic Urticaria Market, Revenues & Volume, By Therapeutic Class, 2021 - 2031 |
11.4 Europe Chronic Urticaria Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
11.5 Europe Chronic Urticaria Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
12 Middle East Chronic Urticaria Market, Overview & Analysis |
12.1 Middle East Chronic Urticaria Market Revenues & Volume, 2021 - 2031 |
12.2 Middle East Chronic Urticaria Market, Revenues & Volume, By Countries, 2021 - 2031 |
12.2.1 Saudi Arabia Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
12.2.2 UAE Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
12.2.3 Turkey Chronic Urticaria Market, Revenues & Volume, 2021 - 2031 |
12.3 Middle East Chronic Urticaria Market, Revenues & Volume, By Therapeutic Class, 2021 - 2031 |
12.4 Middle East Chronic Urticaria Market, Revenues & Volume, By Route of Administration, 2021 - 2031 |
12.5 Middle East Chronic Urticaria Market, Revenues & Volume, By Distribution Channel, 2021 - 2031 |
13 Global Chronic Urticaria Market Key Performance Indicators |
14 Global Chronic Urticaria Market - Export/Import By Countries Assessment |
15 Global Chronic Urticaria Market - Opportunity Assessment |
15.1 Global Chronic Urticaria Market Opportunity Assessment, By Countries, 2021 & 2031F |
15.2 Global Chronic Urticaria Market Opportunity Assessment, By Therapeutic Class, 2021 & 2031F |
15.3 Global Chronic Urticaria Market Opportunity Assessment, By Route of Administration, 2021 & 2031F |
15.4 Global Chronic Urticaria Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
16 Global Chronic Urticaria Market - Competitive Landscape |
16.1 Global Chronic Urticaria Market Revenue Share, By Companies, 2024 |
16.2 Global Chronic Urticaria Market Competitive Benchmarking, By Operating and Technical Parameters |
17 Top 10 Company Profiles |
18 Recommendations |
19 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here